HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pronounced antiepileptic activity of the subtype-selective GABAA -positive allosteric modulator PF-06372865 in the GAERS absence epilepsy model.

AbstractAIM:
Antiepileptic drugs that modulate GABA have the potential to aggravate or improve the symptoms of absence epilepsy. PF-06372865 is a positive allosteric modulator (PAM) of α2/3/5 subunit-containing GABAA receptors with minimal activity at α1-containing receptors, which are believed to mediate many of the adverse events associated with benzodiazepines. The aim of this study was to assess the antiepileptic effect of PF-06372865 in a preclinical model of absence seizures.
METHODS:
Genetic absence epilepsy rats from Strasbourg (GAERS) was implanted with four cortical electrodes over the frontoparietal cortex, and the number and cumulated duration of spike-and-wave discharges (SWDs) were recorded for 10-90 minutes following administration of vehicle, PF-06372865, and positive controls diazepam and valproate.
RESULTS:
PF-06372865 (0.3, 1, 2, 10 mg kg-1 ) dose-dependently reduced the expression of SWDs, including full suppression at the highest doses by 30 minutes after administration.
CONCLUSIONS:
PF-06372865 demonstrated robust efficacy in suppressing SWDs in the GAERS model of absence epilepsy. To our knowledge, this is the first demonstration of antiepileptic activity of an α2/3/5-subtype-selective GABAA PAM in a model of absence epilepsy. Further study of the antiepileptic properties of PF-06372865 is warranted in patients with absence seizures.
AuthorsVenceslas Duveau, Derek L Buhl, Alexis Evrard, Céline Ruggiero, Betty Mandé-Niedergang, Corinne Roucard, Rachel Gurrell
JournalCNS neuroscience & therapeutics (CNS Neurosci Ther) Vol. 25 Issue 2 Pg. 255-260 (02 2019) ISSN: 1755-5949 [Electronic] England
PMID30101518 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 John Wiley & Sons Ltd.
Chemical References
  • Anticonvulsants
  • GABA Modulators
  • Imidazoles
  • PF-06372865
  • Pyridazines
  • Receptors, GABA-A
  • Valproic Acid
  • Diazepam
Topics
  • Animals
  • Anticonvulsants (therapeutic use)
  • Diazepam (therapeutic use)
  • Dose-Response Relationship, Drug
  • Electrocorticography
  • Electrodes, Implanted
  • Electroencephalography
  • GABA Modulators (therapeutic use)
  • Imidazoles (therapeutic use)
  • Male
  • Pyridazines (therapeutic use)
  • Rats
  • Receptors, GABA-A (drug effects)
  • Seizures (drug therapy)
  • Valproic Acid (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: